Solazyme (NASDAQ: SZYM) announced hat the US Food and Drug Administration (FDA) has issued a favorable response to Solazyme’s notification ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE